118th Congress · HOUSE BILLBILL

H.R. 1117Advancing Safe Medications for Moms and Babies Act of 2023

To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.

Health
Introduced Feb 21, 2023
Last action Mar 3, 2023
Pipeline · Bill → Law
Step 1
Introduced
Feb 21, 2023
Step 2
Referred
Mar 3, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research. For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research. The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance...

Provisions · 6 sectionsIntroduced in House
Timeline · 3 actions
Mar 3, 2023
Referred to the Subcommittee on Health.
Feb 21, 2023
Introduced in House
Feb 21, 2023
Referred to the House Committee on Energy and Commerce.